Saturday, 27 August 2016

Amid EpiPen Furor, a CEO Shows How Not to Swim Against the Tide

Mylan's crisis response to high EpiPen prices is focused on an important goal: changing the national conversation on health pricing.


source http://feedproxy.google.com/~r/entrepreneur/latest/~3/IhHTVgsENSw/281504
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)